FindTrial
Sign In

Study of ovarian tumors and its genetic material in blood

Study of circulating microRNA 200c in Ovarian neoplasms - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/06/068702
Enrollment
30
Registered
2024-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D279- Benign neoplasm of unspecified ovary Health Condition 2: C569- Malignant neoplasm of unspecifiedovary Health Condition 3: D391- Neoplasm of uncertain behavior ofovary

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Radiologically suspected cases of primary ovarian neoplasms

Exclusion criteria

Exclusion criteria: 1. Patients receiving chemotherapy and/or radiotherapy. 2. Histopathologically confirmed non ovarian neoplasms.

Design outcomes

Primary

MeasureTime frame
Delta Ct value and Standard deviation of microRNA 200c levels in primary ovarian neoplasms in peripheral bloodTimepoint: Baseline—

Secondary

MeasureTime frame
1. Comparison of the levels of microRNA 200c in benign, borderline and malignant neoplasms. 2. Association of expression with clinico-pathological parameters.Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Khuraijam Bembem

Maulana Azad Medical College

bemkhuraijam@gmail.com9811570454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026